Biliopancreatic Diversion with Duodenal Switch in Patients with Type 2 Diabetes mellitus: Is the Chance of Complete Remission Dependent on Therapy and Duration of Insulin Treatment?

被引:9
|
作者
Cho, Eun-Young [1 ]
Kemmet, Olga [1 ]
Frenken, Michael [1 ]
机构
[1] St Josef Krankenhaus Monheim, Dept Surg, D-40789 Monheim, Germany
关键词
Biliopancreatic diversion with duodenal switch; BPD-DS; Type 2 diabetes mellitus; Complete remission; Insulin; OBESE-PATIENTS; SENSITIVITY; GLUCOSE; RESISTANCE; SURGERY; TERM;
D O I
10.1159/000327037
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Rapid resolution of type 2 diabetes mellitus (T2DM) is a common feature after intestinal bypass surgery bypassing the duodenum and parts of the jejunum. However, the parameters determining the individual chance of remission are imprecisely defined. Methods: Biliopancreatic diversion with duodenal switch and sleeve gastrectomy (BPD-DS) was performed in n = 86 patients with T2DM (mean age 50 years, range 26-68, 51 females; BMI 47 kg/m(2), range 26-71). The patients were retrospectively divided into 4 groups according to the treatment modality and the duration of insulin treatment preoperatively: n = 18 patients were treated with oral antidiabetic drugs only (group 1); n = 32, n = 24, and n = 12 patients were treated with insulin for less than 5 years, for 5-10 years, and for more than 10 years (groups 2, 3, and 4), respectively. Results: At discharge from hospital, all patients of groups 1 and 2 were free of insulin usage, 30% and 75% of the patients of groups 3 and 4 used up to 48 units of insulin per day (mean 24, n = 16). After 1 year, only 4 patients of group 4 permanently required small amounts of insulin (mean 17 units per day) to keep blood glucose below 200 mg/dl. These 4 patients had been using insulin preoperatively for 13, 15, 22, and 25 years. In 3 of these 4 patients, fasting C-peptide was measured and found to be low (<1.2 ng/ml). The rate of complete remission of diabetes for the whole study population was 91%. Conclusion: BPD-DS reliably causes rapid and complete remission of T2DM in all patients on oral antidiabetic drugs and in patients with insulin treatment for less than 5 years. In patients with insulin treatment longer than 5 or 10 years, complete remission rates decline to 88 and 66%, respectively. A low C-peptide preoperatively might be a specific adverse prognostic parameter for the chance of diabetes remission.
引用
收藏
页码:18 / 23
页数:6
相关论文
共 50 条
  • [41] Characteristics Predictive for a Successful Switch from Insulin Analogue Therapy to Oral Hypoglycemic Agents in Patients with Type 2 Diabetes
    Kim, Gyuri
    Lee, Yong-ho
    Kang, Eun Seok
    Cha, Bong-Soo
    Lee, Hyun Chul
    Lee, Byung-Wan
    YONSEI MEDICAL JOURNAL, 2016, 57 (06) : 1395 - 1403
  • [42] Remission of diabetes mellitus type 2 with severe hyperglycemia after Exenatide treatment
    Al-Jebawi, Ahmed F.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2010, 90 (03) : E88 - E90
  • [43] Insulin Therapy for Adult Patients with Type 2 Diabetes Mellitus: A Position Statement of the Korean Diabetes Association, 2017
    Lee, Byung-Wan
    Kim, Jin Hwa
    Ko, Seung-Hyun
    Hur, Kyu-Yeon
    Kim, Nan-Hee
    Rhee, Sang Youl
    Kim, Hyun Jin
    Moon, Min Kyong
    Park, Seok-O
    Choi, Kyung Mook
    DIABETES & METABOLISM JOURNAL, 2017, 41 (05) : 367 - 373
  • [44] Combination insulin and sulfonylurea therapy in insulin-requiring type 2 diabetes mellitus
    Feinglos, MN
    Thacker, CR
    Lobaugh, B
    DeAtkine, DD
    McNeill, DB
    English, JS
    Bursey, DL
    DIABETES RESEARCH AND CLINICAL PRACTICE, 1998, 39 (03) : 193 - 199
  • [45] Current perspective on the role of insulin and glucagon in the pathogenesis and treatment of type 2 diabetes mellitus
    Ojha, Ashutosh
    Ojha, Utkarsh
    Mohammed, Raihan
    Chandrashekar, Abhinaya
    Ojha, Harsh
    CLINICAL PHARMACOLOGY-ADVANCES AND APPLICATIONS, 2019, 11 : 57 - 65
  • [46] Insulin therapy for adult patients with type 2 diabetes mellitus: a position statement of the Korean Diabetes Association, 2017
    Lee, Byung-Wan
    Kim, Jin Hwa
    Ko, Seung-Hyun
    Hur, Kyu Yeon
    Kim, Nan-Hee
    Rhee, Sang Youl
    Kim, Hyun Jin
    Moon, Min Kyong
    Park, Seok-O
    Choi, Kyung Mook
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2017, 32 (06) : 967 - 973
  • [47] Investigation of the barriers about insulin therapy in patients with type 2 diabetes
    Soylar, P.
    Kadioglu, B. U.
    Kilic, K.
    NIGERIAN JOURNAL OF CLINICAL PRACTICE, 2020, 23 (01) : 98 - 102
  • [48] Automated insulin therapy in patients with type 2 diabetes
    Heinemann, L.
    DIABETOLOGE, 2013, 9 (04): : 302 - 307
  • [49] Validation and application of the Insulin Treatment Appraisal Scale in Cuban patients with type 2 diabetes mellitus
    Hernandez-Garcia, Frank
    Ernesto Gonzalez-Velazquez, Victor
    Perez Garcia, Enrique Rolando
    Lazo Herrera, Luis Alberto
    Maria Pedraza-Rodriguez, Elys
    Pupo Perez, Antonio
    Gonzalez Quintana, Patricia
    Casanovas Figueroa, Jany
    ENDOCRINOLOGIA DIABETES Y NUTRICION, 2022, 69 (10): : 791 - 801
  • [50] Early Discontinuation and Restart of Insulin in the Treatment of Type 2 Diabetes Mellitus
    Haya Ascher-Svanum
    Maureen J. Lage
    Magaly Perez-Nieves
    Matthew D. Reaney
    Joanne Lorraine
    Angel Rodriguez
    Michael Treglia
    Diabetes Therapy, 2014, 5 : 225 - 242